240 related articles for article (PubMed ID: 32864776)
1. Three cases of non-atopic hyperkeratotic hand eczema treated with dupilumab.
Loman L; Diercks GFH; Schuttelaar MLA
Contact Dermatitis; 2021 Feb; 84(2):124-127. PubMed ID: 32864776
[No Abstract] [Full Text] [Related]
2. Treatment of hyperkeratotic dermatitis of the palms. Sequential treatment with a keratolytic gel and corticosteroid ointment.
Baden HP
Arch Dermatol; 1974 Nov; 110(5):737-8. PubMed ID: 4424786
[No Abstract] [Full Text] [Related]
3. Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study.
Oosterhaven JAF; Voorberg AN; Romeijn GLE; de Bruin-Weller MS; Schuttelaar MLA
J Dermatol; 2019 Aug; 46(8):680-685. PubMed ID: 31187925
[TBL] [Abstract][Full Text] [Related]
4. Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis.
Halling AS; Loft N; Silverberg JI; Guttman-Yassky E; Thyssen JP
J Am Acad Dermatol; 2021 Jan; 84(1):139-147. PubMed ID: 32822798
[TBL] [Abstract][Full Text] [Related]
5. Dupixent® (Dupilumab): A Newly Approved Interleukin-4 Receptor Antagonist for the Treatment of Atopic Dermatitis in Pediatric Patients.
Gupta AK; Love RP; Abramovits W; Vincent KD
Skinmed; 2019; 17(2):107-109. PubMed ID: 31145061
[No Abstract] [Full Text] [Related]
6. A Retrospective Review of Dupilumab for Hand Dermatitis.
Lee N; Chipalkatti N; Zancanaro P; Kachuk C; Dumont N; Rosmarin D
Dermatology; 2019; 235(3):187-188. PubMed ID: 30726838
[No Abstract] [Full Text] [Related]
7. Alitretinoin and acitretin in severe chronic hand eczema; results from a retrospective daily practice study.
Politiek K; Christoffers WA; Coenraads PJ; Schuttelaar MA
Dermatol Ther; 2016 Sep; 29(5):364-371. PubMed ID: 27146260
[TBL] [Abstract][Full Text] [Related]
8. Case study 1--A 54-year-old male gardener with chronic hand eczema.
English J
Clin Exp Dermatol; 2011 Mar; 36 Suppl():3-4. PubMed ID: 21309811
[No Abstract] [Full Text] [Related]
9. Dupilumab Treatment of Very Severe Refractory Atopic Hand Eczema.
Oosterhaven JAF; Romeijn GLE; Schuttelaar MLA
JAMA Dermatol; 2018 Aug; 154(8):969-970. PubMed ID: 29971331
[No Abstract] [Full Text] [Related]
10. Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study.
Johansson EK; Ivert LU; Bradley B; Lundqvist M; Bradley M
BMC Dermatol; 2020 Sep; 20(1):8. PubMed ID: 32962676
[TBL] [Abstract][Full Text] [Related]
11. Severe treatment-resistant acute and recurrent vesicular chronic hand eczema successfully treated with dupilumab.
Halling AS; Zachariae C; Thyssen JP
Contact Dermatitis; 2020 Jul; 83(1):37-38. PubMed ID: 32087035
[No Abstract] [Full Text] [Related]
12. Successful use of dupilumab for the treatment of atopic dermatitis on the genitals, a neglected anatomical site.
Paolino G; Sernicola A; Di Nicola MR; Foti A; Brianti P; Vaira F; Grieco T; Mercuri SR
Clin Exp Dermatol; 2022 Jan; 47(1):176-178. PubMed ID: 34398987
[TBL] [Abstract][Full Text] [Related]
13. Urea in the topical treatment of atopic eczema.
Hindson TC
Arch Dermatol; 1971 Sep; 104(3):284-5. PubMed ID: 5096834
[No Abstract] [Full Text] [Related]
14. Long-term, intermittent treatment of chronic hand eczema with mometasone furoate.
Veien NK; Olholm Larsen P; Thestrup-Pedersen K; Schou G
Br J Dermatol; 1999 May; 140(5):882-6. PubMed ID: 10354026
[TBL] [Abstract][Full Text] [Related]
15. Dupilumab, an emerging therapeutic choice for recalcitrant subepidermal autoimmune bullous diseases: a case series of three patients.
Liu X; Ma J; Qiu X; Hong D; Wang L; Shi Z
Eur J Dermatol; 2021 Dec; 31(6):846-847. PubMed ID: 35107075
[No Abstract] [Full Text] [Related]
16. Hand dermatitis/eczema: current management strategy.
Sehgal VN; Srivastava G; Aggarwal AK; Sharma AD
J Dermatol; 2010 Jul; 37(7):593-610. PubMed ID: 20629825
[TBL] [Abstract][Full Text] [Related]
17. Case study 2--A 33-year-old female horse trainer with long-standing hand and foot eczema.
English J
Clin Exp Dermatol; 2011 Mar; 36 Suppl():5-6. PubMed ID: 21309812
[No Abstract] [Full Text] [Related]
18. [Local treatments of eczema].
Delanoe J; Puissant A
Sem Hop; 1978 Feb; 54(4):239-41. PubMed ID: 208175
[No Abstract] [Full Text] [Related]
19. Blocking type 2 inflammation by dupilumab does not control classic (type 1-driven) allergic contact dermatitis in chronic hand eczema.
Crepy MN; Nosbaum A; Bensefa-Colas L
Contact Dermatitis; 2019 Aug; 81(2):145-147. PubMed ID: 30851059
[No Abstract] [Full Text] [Related]
20. Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review.
Hendricks AJ; Yosipovitch G; Shi VY
J Dermatolog Treat; 2021 Feb; 32(1):19-28. PubMed ID: 31693426
[No Abstract] [Full Text] [Related]
[Next] [New Search]
